Alkali Citrate Content of Common Over-the-Counter and Medical Food Supplements
Dai JC, Maalouf NM, Hill K, Antonelli JA, Pearle MS, Johnson BA. J Endourol. 2023 Jan;37(1):112-118. doi: 10.1089/end.2022.0274. Epub 2022 Oct 19
PMID: 35972746

Oxalate disrupts monocyte and macrophage cellular function via Interleukin-10 and mitochondrial reactive oxygen species (ROS) signaling.
Kumar P, Laurence E, Crossman DK, Assimos DG, Murphy MP, Mitchell T. Redox Biol. 2023 Oct 4;67:102919. doi: 10.1016/j.redox.2023.102919. Epub ahead of print.
PMID: 37806112; PMCID: PMC10565874.

Collaboration on Disparities in Kidney Stone Disease. Associations of Obesity and Neighborhood Factors With Urinary Stone Parameters.
Crivelli JJ, Redden DT, Johnson RD, Juarez LD, Maalouf NM, Hughes AE, Wood KD, Assimos G, Oates GR. Am J Prev Med. 2022 Jul;63(1 Suppl 1):S93-S102. doi: 10.1016/j.amepre.2022.01.033
PMID: 35725147; PMCID: PMC9219039.

Financial Toxicity of Nephrolithiasis: The First Assessment of the Economic Stresses of Kidney Stone Treatment.
Green BW, Labagnara K, Feiertag N, Gupta K, Donnelly J, Watts KL, Crivelli JJ, Assimos DG, Small AC. Urology. 2022 Dec;170:46-52. doi: 10.1016/j.urology.2022.08.042. Epub 2022 Sep 29.
PMID: 36183747.

Plant-Based Milk Alternatives and Risk Factors for Kidney Stones and Chronic Kidney Disease
Borin JF, Knight J, Holmes RP, Joshi S, Goldfarb DS, Loeb S. J Ren Nutr. 2022 May;32(3):363-365. doi: 10.1053/j.jrn.2021.03.011. Epub 2021 May 25.
PMID: 34045136; PMCID: PMC8611107.

Dietary Oxalate Loading Impacts Monocyte Metabolism and Inflammatory Signaling in Humans. Front Immunol.
Kumar P, Patel M, Oster RA, Yarlagadda V, Ambrosetti A, Assimos DG, Mitchell T. 2021 Feb 25;12:617508. doi: 10.3389/fimmu.2021.617508.
PMID: 33732242; PMCID: PMC7959803.

"Trust my morphology", the key message from a kidney stone.
Pozdzik A, Van Haute C, Maalouf N, Letavernier E, Williams JC, Sakhaee K. Urolithiasis. 2021 Oct;49(5):493-494. doi: 10.1007/s00240-021-01280-4. Epub 2021 Jul 23.
PMID: 34297156; PMCID: PMC8416829.

Disparities in Kidney Stone Disease: A Scoping Review.
Crivelli JJ, Maalouf NM, Paiste HJ, Wood KD, Hughes AE, Oates GR, Assimos DG.J Urol. 2021 Apr 27:101097JU0000000000001846. doi: 10.1097/JU.0000000000001846. Online ahead of print.
PMID: 33904797

Effect of alanine supplementation on oxalate synthesis.
Wood KD, Freeman BL, Killian ME, Lai WS, Assimos D, Knight J, Fargue S. Biochim Biophys Acta Mol Basis Dis. 2021 Jan 1;1867(1):165981. doi: 10.1016/j.bbadis.2020.165981. Epub 2020 Sep 28.
PMID: 33002578

Screening for primary hyperparathyroidism in a tertiary stone clinic, a useful endeavor.
Boyd CJ, Wood KD, Singh N, Whitaker D, McGwin G, Chen H, Assimos DG. Int Urol Nephrol. 2020 Sep;52(9):1651-1655. doi: 10.1007/s11255-020-02476-0. Epub 2020 May 1.
PMID: 32358674.

End Points for Clinical Trials in Primary Hyperoxaluria.
Milliner DS, McGregor TL, Thompson A, Dehmel B, Knight J, Rosskamp R, Blank M, Yang S, Fargue S, Rumsby G, Groothoff J, Allain M, West M, Hollander K, Lowther WT, Lieske JC. Clin J Am Soc Nephrol. 2020 Jul 1;15(7):1056-1065. doi: 10.2215/CJN.13821119. Epub 2020 Mar 12.
PMID: 32165440; PMCID: PMC7341772.

Contribution of Dietary Oxalate and Oxalate Precursors to Urinary Oxalate Excretion.
Crivelli JJ, Mitchell T, Knight J, Wood KD, Assimos DG, Holmes RP, Fargue S. Nutrients. 2020 Dec 28;13(1):62. doi: 10.3390/nu13010062.
PMID: 33379176 Review

Effects of a carbohydrate-restricted diet on hepatic lipid content in adolescents with non-alcoholic fatty liver disease: A pilot, randomized trial.
Tay, J., Goss, A. M., Garvey, W. T., Lockhart, M. E., Bush, N. C., Quon, M. J., Fisher, G., and Gower, B. A. Pediatr Obes. 2020 Jul;15(7):e12630. doi: 10.1111/ijpo.12630. Epub 2020 Mar 4.
PMID: 32128995

Dietary Oxalate Induces Urinary Nanocrystals in Humans.
Kumar P, Patel M, Thomas V, Knight J, Holmes RP, Mitchell T. Kidney Int Rep. 2020 May 7;5(7):1040-1051. doi: 10.1016/j.ekir.2020.04.029. eCollection 2020 Jul.
PMID: 32647761

Future treatments for hyperoxaluria.
Burns Z, Knight J, Fargue S, Holmes R, Assimos D, Wood K. Curr Opin Urol. 2020 Mar;30(2):171-176. doi: 10.1097/MOU.0000000000000709.
PMID: 31895888

Race affects the association of obesity measures with insulin sensitivity.
Tay, J., Goss, A. M., Garvey, W. T., Lockhart, M. E., Bush, N. C., Quon, M. J., Fisher, G., and Gower, B. A. Am J Clin Nutr. 2020 Mar 1;111(3):515-525. doi: 10.1093/ajcn/nqz309.
PMID: 31879755

Future treatments for hyperoxaluria.
Burns, Z., Knight, J., Fargue, S., Holmes, R., Assimos, D., and Wood, K. Curr Opin Urol. 2020 Mar;30(2):171-176. doi: 10.1097/MOU.0000000000000709.
PMID: 31895888

The effects of the inactivation of Hydroxyproline dehydrogenase on urinary oxalate and glycolate excretion in mouse models of primary hyperoxaluria.
Buchalski B, Wood KD, Challa A, Fargue S, Holmes RP, Lowther WT, Knight J. Biochim Biophys Acta Mol Basis Dis. 2020 Mar 1;1866(3):165633. doi: 10.1016/j.bbadis. 2019.165633. Epub 2019 Dec 7.
PMID: 31821850

Obesity and Kidney Stone Procedures.
Singh NP, Boyd CJ, Poore W, Wood K, Assimos DG. Rev Urol. 2020;22(1):24-29.
PMID: 32523468; PMCID: PMC7265183

Obesity and Kidney Stone Procedures.
William Poore, Carter J. Boyd, Nikhi P. Singh, Kyle Wood, Barbara Gower, and Dean G. Assimos. Rev Urol. 2020;22(1):24-29.
PMID: 32523468

Obesity and Its Impact on Kidney Stone Formation.
William Poore, Carter J. Boyd, Nikhi P. Singh, Kyle Wood, Barbara Gower, and Dean G. Assimos. Rev Urol. 2020;22(1):17-23.
PMID: 32523467

Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity.
Wood KD, Holmes RP, Erbe D, Liebow A, Fargue S, Knight J. Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2203-2209. doi: 10.1016/j.bbadis. 2019.04.017. Epub 2019 May 2.
PMID: 31055082

Dietary oxalate and kidney stone formation.
Mitchell T, Kumar P, Reddy T, Wood KD, Knight J, Assimos DG, Holmes RP. Am J Physiol Renal Physiol. 2019 Mar 1;316(3):F409-F413. doi: 10.1152/ajprenal.00373.2018. Epub 2018 Dec 19.
PMID: 30566003 Review 

Impact of Demographic Factors and Systemic Disease on Urinary Stone Risk Parameters Amongst Stone Formers.
Wood K, Boyd C, Whitaker D, Ashorobi O, Poore W, Gower B, Assimos DG. Rev Urol. 2019;21(4):158-165.
PMID: 32071564

The influence of metabolic syndrome and its components on the development of nephrolithiasis.
Boyd C, Wood K, Whitaker D, Assimos DG. Asian J Urol. 2018 Oct;5(4):215-222. doi: 10.1016/j.ajur.2018.06.002. Epub 2018 Jun 8.
PMID: 30364536 Review

Accuracy in 24-hour Urine Collection at a Tertiary Center.
Boyd C, Wood K, Whitaker D, Ashorobi O, Harvey L, Oster R, Holmes RP, Assimos DG. Rev Urol. 2018;20(3):119-124. doi: 10.3909/riu0807.
PMID: 30473637